IBMS Chief Executive David Wells looks forward to the UK’s most significant biomedical science event.

Later this month we will see the return of IBMS Congress (25–28 September) and, if ticket sales are anything to go by, it will be the most successful one for many years.
Since the great success of IBMS Congress 2022, our specialist panels have gone above and beyond to bring together another impressive roster in a much-reduced timescale. We have an expansive education and lecture programme with over 20 key specialisms and areas of professional interest – with the most innovative and esteemed leaders in their fields talking and presenting.
This year also sees the Association for Clinical Biochemistry and Laboratory Medicine hosting the Laboratory Medicine Leadership Summit at IBMS Congress.
It’s wonderful that this essential strategic meeting for senior laboratory staff and managers, across all pathology disciplines, is now on the agenda.
The sheer scale and depth of the programme demonstrates the IBMS’ primacy in biomedical science and diagnostics – as does having the UK’s largest biomedical science exhibition, featuring the leading diagnostic companies with all the major suppliers and innovators from industry. It is truly the UK’s most significant biomedical science event by far.
I’m also proud of the support that we offer to our eStudents at IBMS Congress – organising the UK’s largest dedicated biomedical science student event with a programme that is free to attend and aimed at jump-starting and informing early careers.
With just over a year between Congresses this time, it will be interesting to see just how quickly the concerns of our profession have shifted and moved, and what has stayed the same.
This year’s theme is “Linking learning to the laboratory” and this, at core, is what the IBMS excels at. However, it is thanks to the efforts of our members who are trainers and managers, researchers and innovators, specialists and advanced clinicians, that we can put on such a fascinating event.
I never lose sight of the fact that IBMS Congress is essentially a display of our membership’s talent and achievements, and I am always overwhelmed by the determined application of our profession’s intelligence and its vision for better patient care.
I can’t wait to get there and learn from the brightest and best that the UK has to offer.
David Wells Chief Executive